Search details
1.
A phase 2 trial of CD24Fc for prevention of graft-versus-host disease.
Blood
; 143(1): 21-31, 2024 01 04.
Article
in English
| MEDLINE | ID: mdl-37647633
2.
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes.
Biol Blood Marrow Transplant
; 26(11): 2139-2146, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32781289
3.
α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease.
Blood
; 131(12): 1372-1379, 2018 03 22.
Article
in English
| MEDLINE | ID: mdl-29437593
4.
MAGIC biomarkers predict long-term outcomes for steroid-resistant acute GVHD.
Blood
; 131(25): 2846-2855, 2018 06 21.
Article
in English
| MEDLINE | ID: mdl-29545329
5.
Assessment of Individual versus Composite Endpoints of Acute Graft-versus-Host Disease in Determining Long-Term Survival after Allogeneic Transplantation.
Biol Blood Marrow Transplant
; 25(8): 1682-1688, 2019 08.
Article
in English
| MEDLINE | ID: mdl-30710686
6.
A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.
Biol Blood Marrow Transplant
; 25(8): 1492-1497, 2019 08.
Article
in English
| MEDLINE | ID: mdl-30959163
7.
Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT.
Blood
; 130(15): 1760-1767, 2017 10 12.
Article
in English
| MEDLINE | ID: mdl-28784598
8.
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.
Blood
; 130(9): 1156-1164, 2017 08 31.
Article
in English
| MEDLINE | ID: mdl-28674027
9.
Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 23(3): 522-528, 2017 Mar.
Article
in English
| MEDLINE | ID: mdl-28017733
10.
Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: A CIBMTR report.
Cancer
; 123(16): 3141-3149, 2017 Aug 15.
Article
in English
| MEDLINE | ID: mdl-28472539
11.
Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial.
Biol Blood Marrow Transplant
; 22(5): 862-8, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26551636
12.
Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series.
Biol Blood Marrow Transplant
; 22(1): 54-60, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26211984
13.
Hematopoietic Cell Transplantation Outcomes in Monosomal Karyotype Myeloid Malignancies.
Biol Blood Marrow Transplant
; 22(2): 248-257, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26327629
14.
Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation.
Br J Haematol
; 174(2): 235-48, 2016 07.
Article
in English
| MEDLINE | ID: mdl-26989808
15.
Quantitative Analysis of MR Imaging to Assess Treatment Response for Patients with Multiple Myeloma by Using Dynamic Intensity Entropy Transformation: A Preliminary Study.
Radiology
; 278(2): 449-57, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26192897
16.
Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung.
Biol Blood Marrow Transplant
; 21(6): 1127-31, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25687798
17.
Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remission.
Ann Hematol
; 94(6): 1033-41, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25784222
18.
Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell transplantation: a phase 1/2 trial.
Lancet Oncol
; 15(1): 87-95, 2014 Jan.
Article
in English
| MEDLINE | ID: mdl-24295572
19.
Etanercept plus topical corticosteroids as initial therapy for grade one acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Biol Blood Marrow Transplant
; 20(9): 1426-34, 2014 Sep.
Article
in English
| MEDLINE | ID: mdl-24892263
20.
Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE-BMT Risk Score.
J Am Heart Assoc
; 13(1): e033599, 2024 Jan 02.
Article
in English
| MEDLINE | ID: mdl-38158222